Safety and immunogenicity of a measles-mumps-rubella-varicella vaccine given as a second dose in children up to six years of age

Vaccine

Volumn 27, Issue 20, 2009, Pages 2701-2706

  Halperin, Scott A ^a   Ferrera, Giuseppe ^b   Scheifele, David ^c   Predy, Gerald ^d   Stella, Giuseppe ^e   Cuccia, Mario ^f   Douha, Martine ^g   Willems, Paul ^g  

^a DALHOUSIE UNIVERSITY   (Canada)

^b AUSL 7 di Ragusa   (Italy)

^c UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^d Capital Health Edmonton   (Canada)

^e Servizio Igiene e Sanità Pubblica   (Italy)

^f AUSL 3   (Italy)

^g GLAXOSMITHKLINE BIOLOGICALS   (Belgium)

Author keywords

Combination vaccine; Measles mumps rubella varicella vaccine; Safety and immunogenicity

Indexed keywords

CHICKENPOX MEASLES MUMPS RUBELLA VACCINE; CHICKENPOX VACCINE; MEASLES MUMPS RUBELLA VACCINE; PRIORIX TETRA; UNCLASSIFIED DRUG; VARICELLA ZOSTER VACCINE;

ANTIBODY RESPONSE; ARTICLE; CHICKENPOX; CHILD; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG SAFETY; FEMALE; FEVER; HUMAN; IMMUNIZATION; IMMUNOGENICITY; INCIDENCE; INFECTION PREVENTION; INJECTION SITE ERYTHEMA; INJECTION SITE PAIN; INJECTION SITE SWELLING; MAJOR CLINICAL STUDY; MALE; MEASLES; MULTICENTER STUDY; MUMPS; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RUBELLA; SEROCONVERSION; SYMPTOM;

ANTIBODIES, VIRAL; CHICKENPOX VACCINE; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; IMMUNIZATION, SECONDARY; INFANT; MALE; MEASLES-MUMPS-RUBELLA VACCINE;

EID: 64549126437     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2009.02.044     Document Type: Article

References (32)

1. Watson J.C., Hadler S.C., Dykewicz C.A., Reef S., and Phillips L. Measles, mumps, and rubella-vaccine use and strategies for elimination of measles, rubella, and congenital rubella syndrome and control of mumps: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 47 RR-8 (1998) 1-57
2. World Health Organization. Measles vaccines. Wkly Epidemiol Rec 79 (2004) 130-142
3. Ong G., Rasidah N., Wan S., and Cutter J. Outbreak of measles in primary school students with high first dose MMR vaccination coverage. Singapore Med J 48 (2007) 656-661
4. Paunio M., Peltola H., Valle M., Davidkin I., Virtanen M., and Heinonen O.P. Twice vaccinated recipients are better protected against epidemic measles than are single dose recipients of measles containing vaccine. J Epidemiol Community Health 53 (1999) 173-178
5. Hinman A.R., Orenstein W.A., and Papania M.J. Evolution of measles elimination strategies in the United States. J Infect Dis 189 Suppl 1 (2004) S17-22
6. Peltola H., Heinonen O., Valle M., Paunio M., Virtanen M., Karanko V., et al. Elimination of indigenous measles, mumps and rubella from Finland by a 12-year, two-dose vaccination program. N Engl J Med 331 (1994) 1397-1402
7. Centers for Disease Control and Prevention (CDC). Mumps epidemic-Iowa, 2006. MMWR Morb Mortal Wkly Rep 55 (2006) 366-368
8. Schmid D., Pichler A.M., Wallenko H., Holzmann H., and Allerberger F. Mumps outbreak affecting adolescents and young adults in Austria, 2006. Euro Surveill 11 6 (2006) E060615.1
9. Watson-Creed G., Saunders A., Scott J., Lowe L., Pettipas J., and Hatchette T.F. Two successive outbreaks of mumps in Nova Scotia among vaccinated adolescents and young adults. CMAJ 175 (2006) 483-488
10. Centers for Disease Control and Prevention (CDC). Updated recommendations of the Advisory Committee on Immunization Practices (ACIP) for the control and elimination of mumps. MMWR Morb Mortal Wkly Rep 55 (2006) 629-630
11. Committee on Infectious Diseases. Prevention of varicella: recommendations for use of varicella vaccines in children including a recommendation for a routine 2-dose varicella immunization schedule. Pediatrics 120 (2007) 221-231
12. Marin M., Güris D., Chaves S.S., Schmid S., Seward J.F., Advisory Committee on Immunization Practices, and Centers for Disease Control and Prevention (CDC). Prevention of varicella: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 56 RR-4 (2007) 1-40
13. Chaves S.S., Gargiullo P., Zhang J.X., Given R., Guris D., Mascola L., et al. Loss of vaccine-induced immunity to varicella over time. N Engl J Med 356 (2007) 1121-1129
14. Sengupta N., Booy R., Schmitt H.J., Peltola H., Van-Damme P., Schumacher R.F., et al. Varicella vaccination in Europe: are we ready for a universal childhood programme?. Eur J Pediatr 167 (2008) 47-55
15. Vesikari T., Sadzot-Delvaux C., Rentier B., and Gershon A. Increasing coverage and efficiency of measles, mumps, and rubella vaccine and introducing universal varicella vaccination in Europe: a role for the combined vaccine. Pediatr Infect Dis J 26 (2007) 632-638
16. Centers for Disease Control and Prevention (CDC)AT Combination vaccines for childhood immunization: recommendations of the Advisory Committee on Immunization Practices (ACIP), the American Academy of Pediatrics (AAP), and the American Academy of Family Physicians. MMWR Recomm Rep 48 RR-5 (1999) 1-14.
17. Dodd D. Benefits of combination vaccines: effective vaccination on a simplified schedule. Am J Manag Care 9 1 Suppl (2003) S6-12
18. Empfehlungen der Ständigen Impfkommission (STIKO) am Robert Koch-Institut/Stand: Juli 2004. Epidemiologisches Bull 30 (2004) 235-250
19. D'Ancona F., Alfonsi V., Caporali M., Ranghiasci A., and Ciofi Degli Atti M. Pneumococcal conjugate, meningococcal C and varicella vaccination in Italy. Euro Surveill 12 2 (2007) 25-28
20. Nguyen H.Q., Jumaan A.O., and Seward J.F. Decline in mortality due to varicella after implementation of varicella vaccination in the United States. N Engl J Med 352 (2005) 450-458
21. Zhou F., Harpaz R., Jumaan A.O., Winston C.A., and Shefer A. Impact of varicella vaccination on health care utilization. JAMA 294 (2005) 797-802
22. Centers for Disease Control and Prevention, (CDC), 2004. Outbreak of varicella among vaccinated children-Michigan, 2003. MMWR Morb Mortal Wkly Rep 53 (2004) 389-392
23. Dworkin M.S., Jennings C.E., Roth-Thomas J., Lang J.E., Stukenberg C., and Lumpkin J.R. An Outbreak of Varicella among children attending preschool and elementary school in Illinois. Clin Infect Dis 35 (2002) 102-104
24. Galil K., Lee B., Strine T., Carraher C., Baughman A.L., Eaton M., et al. Outbreak of varicella at a day-care center despite vaccination. N Engl J Med 347 (2002) 1909-1915
25. Lee B.R., Feaver S.L., Miller C.A., Hedberg C.W., and Ehresmann K.R. An elementary school outbreak of varicella attributed to vaccine failure: policy implications. J Infect Dis 190 (2004) 477-483
26. Lopez A.S., Guris D., Zimmerman L., Gladden L., Moore T., Haselow D.T., et al. One dose of varicella vaccine does not prevent school outbreaks: is it time for a second dose?. Pediatrics 117 (2006) e1070-e1077
27. Tugwell B.D., Lee L.E., Gillette H., Lorber E.M., Hedberg K., and Cieslak P.R. Chickenpox outbreak in a highly vaccinated school population. Pediatrics 113 (2004) 455-459
28. Arvin A., and Gerson A. Control of varicella: why is a two-dose schedule necessary?. Pediatr Infect Dis J 25 (2006) 475-476
29. Vesikari T., Baer M., and Willems P. Immunogenicity and safety of a second dose of measles-mumps-rubella-varicella vaccine in healthy children aged 5 to 6 years. Pediatr Infect Dis J 26 (2007) 153-158
30. Goh P., Lim F.S., Han H.H., and Willems P. Safety and immunogenicity of early vaccination with two doses of tetravalent measles-mumps-rubella-varicella (MMRV) vaccine in healthy children from 9 months of age. Infection 35 (2007) 326-333
31. Knuf M., Habermehl P., Zepp F., Mannhardt W., Kuttnig M., Muttonen P., et al. Immunogenicity and safety of two doses of tetravalent measles-mumps-rubella-varicella vaccine in healthy children. Pediatr Infect Dis J 25 (2006) 12-18
32. Schuster V., Otto W., Maurer L., Tcherepnine P., Pfletschinger U., Kindler K., et al. Immunogenicity and safety assessments after one and two doses of a refrigerator-stable tetravalent measles-mumps-rubella-varicella vaccine in healthy children during the second year of life. Pediatr Infect Dis J 27 (2008) 724-730